Yihan Li
- Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies 21
- Spondyloarthritis Studies and Treatments 6
- Systemic Lupus Erythematosus Research 6
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research 15
- Immunology top 10%
- Biosimilars and Bioanalytical Methods 4
- Psoriasis: Treatment and Pathogenesis 4
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 5
- Oncology top 10%
-
- Statistical Methods in Clinical Trials 8
- Co-authors
- Louis BessetteMohamed I. A. OthmanAileen L. PanganYijie ZhouIn‐Ho SongMark C. GenoveseRoy FleischmannPatrick Durez
- Cited by
- RheumatologyHematologyImmunology
- Journals
- Annals of the Rheumatic Diseases (7 papers)Contemporary Clinical Trials (4 papers)Lara D. Veeken (3 papers)
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
Yihan Li
34 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 81
- Rheumatology 961
- Hematology 536
- Immunology 404
- Genetics 203
- Oncology 247
Countries citing papers authored by Yihan Li
This map shows the geographic impact of Yihan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yihan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yihan Li more than expected).
Fields of papers citing papers by Yihan Li
This network shows the impact of papers produced by Yihan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yihan Li. The network helps show where Yihan Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yihan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 12 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 86 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 8 | |
| 11 | 2020 | 19 | |
| 12 | 2019 | 4 | |
| 13 | 2019 | 115 | |
| 14 | Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trialbreakdown → | 2018 | 294 |
| 15 | 2018 | 4 | |
| 16 | 2018 | 1 | |
| 17 | 2017 | 7 | |
| 18 | 2017 | 17 | |
| 19 | 2015 | 20 | |
| 20 | 2014 | 7 |
About Yihan Li
Yihan Li is a scholar working on Rheumatology, Hematology and Statistics and Probability, having authored 34 papers that have together received 1.3k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (21 papers), Autoimmune and Inflammatory Disorders Research (15 papers), Statistical Methods in Clinical Trials (8 papers), Spondyloarthritis Studies and Treatments (6 papers), Systemic Lupus Erythematosus Research (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Biosimilars and Bioanalytical Methods (4 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). The work is most often cited by research in Rheumatology (961 citations), Hematology (536 citations) and Immunology (404 citations). Yihan Li has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Louis Bessette, Mohamed I. A. Othman, Aileen L. Pangan, Yijie Zhou, In‐Ho Song, Mark C. Genovese, Roy Fleischmann, Patrick Durez, Charles Peterfy and Eduardo Mysler. Their work appears in journals such as Annals of the Rheumatic Diseases, Contemporary Clinical Trials, Lara D. Veeken, Arthritis & Rheumatology and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.